Health and Fitness Health and Fitness
Wed, February 29, 2012
[ Wed, Feb 29th 2012 ] - Market Wire
CONMED Corporation Announces Cash Dividend Policy and Declares Initial Quarterly Cash Dividend
[ Wed, Feb 29th 2012 ] - Market Wire
Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Anika Therapeutics Reports 25% Increase in Fourth-Quarter Revenue
[ Wed, Feb 29th 2012 ] - Market Wire
ProPhase Labs to Release Fourth Quarter Results on Tuesday, March 6th
[ Wed, Feb 29th 2012 ] - Market Wire
Phase III studies of Jakafia" (ruxolitinib) publi .. al of Medicine Demonstrate Significant Clinical B
[ Wed, Feb 29th 2012 ] - Market Wire
Nuvo Research announces 2011 fourth quarter & year-end results
[ Wed, Feb 29th 2012 ] - Market Wire
MEDNAX to Present at Raymond James 33rd Annual Institutional Investors Conference in Orlando, Fla.
[ Wed, Feb 29th 2012 ] - Market Wire
MannKind to Present at Cowen and Company 32nd Annual Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Nuvo Research announces 2011 fourth quarter amp;; year-end results
[ Wed, Feb 29th 2012 ] - Market Wire
Gilead Sciences to Present at the Cowen & Company .. nual Health Care Conference on Wednesday, March 7
[ Wed, Feb 29th 2012 ] - Market Wire
Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results
[ Wed, Feb 29th 2012 ] - Market Wire
NuPathe Announces Allowance of U.S. Patent Application for NP202
[ Wed, Feb 29th 2012 ] - Market Wire
Synta to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Amerigroup Named to 2012 quot;;Best Places to Work in Virginiaquot;; List
[ Wed, Feb 29th 2012 ] - Market Wire
Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences
[ Wed, Feb 29th 2012 ] - Market Wire
Thermo Fisher Scientific Initiates Dividend
[ Wed, Feb 29th 2012 ] - Market Wire
Cadence Pharmaceuticals' CEO Ted Schroeder to Pre .. y 32nd Annual Health Care Conference in Boston on
[ Wed, Feb 29th 2012 ] - Market Wire
Accuray Recognized for Delivering 'World-Class' Customer Service
[ Wed, Feb 29th 2012 ] - Market Wire
Hubei Minkang Pharmaceutical Co., Ltd. Signs an MOU with Henan Wanlong Pharmaceutical
[ Wed, Feb 29th 2012 ] - Market Wire
Natus to Present at Upcoming Financial Conferences
[ Wed, Feb 29th 2012 ] - Market Wire
Health Net of California Expands Access to Hispanic-Focused Health Care in Kern County
[ Wed, Feb 29th 2012 ] - Market Wire
Neurocrine Biosciences to Present at the 32nd Annual Cowen Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Loewen, Ondaatje, McCutcheon Initiates Independent Analyst Coverage on Cynapsus Therapeutics
[ Wed, Feb 29th 2012 ] - Market Wire
Grandparents.com, Inc. Announces Funding of $5,00 .. ,000 in Reverse Acquisition With NorWesTech, Inc.
[ Wed, Feb 29th 2012 ] - Market Wire
YM BioSciences Raises US$80.5 Million from Public Offering
[ Wed, Feb 29th 2012 ] - Market Wire
AMI Research Initiates Analyst Coverage on Pressure BioSciences, Inc.;; BUY
[ Wed, Feb 29th 2012 ] - Market Wire
Ergoresearch LTD Reports Record Sales and Claims its Twentieth Consecutive Profitable Quarter
[ Wed, Feb 29th 2012 ] - Market Wire
ImmunoCellular Therapeutics Licenses Mesothelin Cancer Antigen from Johns Hopkins University
[ Wed, Feb 29th 2012 ] - Market Wire
Baxter to Present at the Barclays Capital 2012 Global Healthcare Conference

Baxter to Present at the Barclays Capital 2012 Global Healthcare Conference


Published on 2012-02-29 06:26:24 - Market Wire
  Print publication without navigation


DEERFIELD, Ill.--([ ])--Baxter International Inc. (NYSE: BAX) announced today that it will present at Barclays Capital 2012 Global Healthcare Conference on Wednesday, March 14, 2012, at 10:15 a.m. (ET).

The live webcast of Baxteras presentation can be accessed from the Baxter corporate website at [ www.baxter.com ] and will be available for replay through April 15, 2012.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Contributing Sources